Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/34406626/ below:

Impact of the COVID-19 Pandemic on Colorectal Cancer Screening: a Systematic Review

Review

Affiliations

• ¹ Shiraz University of Medical Sciences, Shiraz, Iran.
• ² Department of Midwifery and Reproductive Health, Mother and Child Care Research Center, School of Nursing and Midwifery, Hamadan University of Medical Sciences, Hamadan, Iran.
• ³ Social Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand, Iran. alesaleh70@yahoo.com.

• PMID: 34406626
• PMCID: PMC8371036
• DOI: 10.1007/s12029-021-00679-x

Item in Clipboard

Review

Afrooz Mazidimoradi et al. J Gastrointest Cancer. 2022 Sep.

• ¹ Shiraz University of Medical Sciences, Shiraz, Iran.
• ² Department of Midwifery and Reproductive Health, Mother and Child Care Research Center, School of Nursing and Midwifery, Hamadan University of Medical Sciences, Hamadan, Iran.
• ³ Social Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand, Iran. alesaleh70@yahoo.com.

• PMID: 34406626
• PMCID: PMC8371036
• DOI: 10.1007/s12029-021-00679-x

Item in Clipboard

Background: After the World Health Organization (WHO) announcing about global pandemic of COVID-19 in March 2020 and relocation of health care resources for controlling this infection, cancer screening programs especially colorectal cancer (CRC) have been suspended in many countries. According to GLOBOCAN 2020 data, CRC is the third prevalent and second deadliest cancer in the world. So, early detection through screening is essential to reduce the mortality associated with this cancer. The present study was designed to investigate the impact of COVID-19 pandemic on colorectal cancer screening.

Methods and materials: A comprehensive search performed on June 2021 in various databases, including Medline, Web of Science, and Scopus. Keywords such as "Early Detection," "Cancer," "Cancer Screening," "Cancer Screening Tests," "Coronavirus Disease-19," "COVID 19," "Coronavirus Disease," "SARS-CoV-2 Infection," "SARS-CoV-2," "2019-nCoV," "coronavirus, 2019 Novel," "SARS COV 2 Virus," "Severe Acute Respiratory Syndrome Coronavirus 2," "COVID-19," "COVID-19, Coronavirus Disease 19," "SARS Coronavirus 2","Colorectal neoplasm" and "Colorectal Cancer" were used individually or in combination to search. All articles were entered into Endnote X7 software that remove duplicates. Then, studies were first selected by title and then by abstract and at the end full texts were investigated.

Results: Of the 850 identified studies, 25 were identified as eligible. The results of studies show that in general, colorectal cancer screening has decreased from 28 to 100% in different countries and at different times after the onset of the COVID-19 pandemic. During this period, only 2 to 2.5% of hospitals and screening centers with 100% capacity continued to operate, and more than 77% of them limited their activities to less than 10% of their normal capacity. Also, completion of colonoscopies requiring examination showed a decrease of 65.7%, surveillance colonoscopy showed a decrease of 44.6 to 79%, prescription colonoscopy decreased 60 to 81%, and referrals to colonoscopy showed a 43% decline. However, emergency colonoscopy shows a 2 to 9% increase. The use of the Fecal immunochemical test (FIT) test is also generally declining but is increasing in areas used as a colonoscopy alternative.

Conclusions: Considering that the reduction in colorectal cancer screening following COVID-19 pandemic is due to the restrictions imposed for the high prevalence of COVID-19 disease and the lack of referrals due to the fear of developing COVID-19 infection; compensating for the decline and preventing the continuation of this decreasing trend requires serious and effective interventions to maintain the capacity of screening services during the COVID-19 crisis, increase the capacity of screening centers during the lifting of restrictions and reduce fear in the public.

Keywords: COVID-19; Colorectal cancer; Screening; Systematic review.

© 2021. Springer Science+Business Media, LLC, part of Springer Nature.

PubMed Disclaimer

The authors declare no competing interests.

Flow of information through the…

Flow of information through the various phases of the systematic review

Flow of information through the various phases of the systematic review

• A Cohort Study of Lt. Col. Luke J. Weathers VA Medical Center Patients with Positive FIT and Incomplete GI Evaluation during the COVID-19 Pandemic.

  Mitchell M, Huynh R, Zhao C, Reaves L, Weir A, Lands L. Mitchell M, et al. South Med J. 2024 Nov;117(11):657-661. doi: 10.14423/SMJ.0000000000001756. South Med J. 2024. PMID: 39486451

• Impact of the COVID-19 Pandemic on Fecal Immunochemical Testing, Colonoscopy Services, and Colorectal Neoplasia Detection in a Large United States Community-based Population.

  Lee JK, Lam AY, Jensen CD, Marks AR, Badalov J, Layefsky E, Kao K, Ho NJ, Schottinger JE, Ghai NR, Carlson CM, Halm EA, Green B, Li D, Corley DA, Levin TR. Lee JK, et al. Gastroenterology. 2022 Sep;163(3):723-731.e6. doi: 10.1053/j.gastro.2022.05.014. Epub 2022 May 14. Gastroenterology. 2022. PMID: 35580655 Free PMC article.

• How COVID-19 Impacted Colonoscopy Utilization and Colorectal Cancer Detection in Hawai'i in 2020.

  Jain A, Jain S, Pagano I. Jain A, et al. Hawaii J Health Soc Welf. 2024 Jul;83(7):200-203. doi: 10.62547/TZCD4005. Hawaii J Health Soc Welf. 2024. PMID: 38974803 Free PMC article.

• Global Impact of COVID-19 on Colorectal Cancer Screening: Current Insights and Future Directions.

  Kopel J, Ristic B, Brower GL, Goyal H. Kopel J, et al. Medicina (Kaunas). 2022 Jan 10;58(1):100. doi: 10.3390/medicina58010100. Medicina (Kaunas). 2022. PMID: 35056408 Free PMC article. Review.

• Screening Colonoscopy for Colon Cancer in Women during COVID-19 Pandemic.

  Bestari MB, Joewono IR. Bestari MB, et al. Acta Med Indones. 2021 Jan;53(1):132-139. Acta Med Indones. 2021. PMID: 33818416 Review.

• Portuguese Results of the ETICC Study: Impact of the Pandemic COVID-19 in the Diagnosis and Management of Colorectal Cancer in 2020 in Portuguese Hospitals.

  Rafael MA, Sequeira C, Isabel da Silva Barros S, Abreu BS, Teixeira C, Lahmek P, Besnard M, Lesgourgues B. Rafael MA, et al. GE Port J Gastroenterol. 2023 Jul 19;31(4):256-261. doi: 10.1159/000531234. eCollection 2024 Aug. GE Port J Gastroenterol. 2023. PMID: 39022304 Free PMC article.

• Measuring the impact of COVID-19 on cancer survival using an interrupted time series analysis.

  Lambert P, Galloway K, Feely A, Bucher O, Czaykowski P, Hebbard P, Kim JO, Pitz M, Singh H, Thiessen M, Decker KM. Lambert P, et al. JNCI Cancer Spectr. 2024 Jan 4;8(1):pkae001. doi: 10.1093/jncics/pkae001. JNCI Cancer Spectr. 2024. PMID: 38177077 Free PMC article.

• Patient Decisions Regarding Rescheduling Colonoscopies Postponed Due to the COVID-19 Pandemic.

  Linz MO, Lorincz-Comi N, Kuwatch AA, Cooper GS. Linz MO, et al. Dig Dis Sci. 2023 Dec;68(12):4339-4349. doi: 10.1007/s10620-023-08119-5. Epub 2023 Oct 4. Dig Dis Sci. 2023. PMID: 37794293

• Patients' views and experiences of delayed diagnosis of inflammatory bowel disease: a qualitative study.

  Cross E, Prior JA, Farmer AD, Saunders B. Cross E, et al. BJGP Open. 2023 Dec 19;7(4):BJGPO.2023.0070. doi: 10.3399/BJGPO.2023.0070. Print 2023 Dec. BJGP Open. 2023. PMID: 37549978 Free PMC article.

• Reimagining Colorectal Cancer Screening: Innovations and Challenges with Dr. Aasma Shaukat.

  Cortiana V, Joshi M, Chorya H, Vallabhaneni H, Kannan S, Coloma HS, Park CH, Leyfman Y. Cortiana V, et al. Cancers (Basel). 2024 May 16;16(10):1898. doi: 10.3390/cancers16101898. Cancers (Basel). 2024. PMID: 38791975 Free PMC article.

1. 1. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N Engl J Med. 2020;382(13):1199–1207. doi: 10.1056/NEJMoa2001316. - DOI - PMC - PubMed
2. 1. Richards M, Anderson M, Carter P, Ebert BL, Mossialos E. The impact of the COVID-19 pandemic on cancer care. Nature Cancer. 2020;1(6):565–567. doi: 10.1038/s43018-020-0074-y. - DOI - PMC - PubMed
3. 1. Kaufman HW, Chen Z, Niles J, Fesko Y. Changes in the number of US patients with newly identified cancer before and during the coronavirus disease 2019 (COVID-19) pandemic. JAMA netw open. 2020;3(8):e2017267. - PMC - PubMed
4. 1. Zahedi A, Rafiemanesh H, Enayatrad M, Ghoncheh M, Salehiniya H. Incidence, Trends and Epidemiology of Cancers in North West of Iran. Asian Pac J Cancer Prev. 2015;16(16):7189–93. doi: 10.7314/APJCP.2015.16.16.7189. - DOI - PubMed
5. 1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 2021;71(3):209–49. - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3